Edwards Lifesciences (WBO:EWLS) Ending Cash Position : €1,131 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Edwards Lifesciences Ending Cash Position?

Edwards Lifesciences's Ending Cash Position for the quarter that ended in Mar. 2024 was €1,131 Mil.

Edwards Lifesciences's quarterly Ending Cash Position declined from Sep. 2023 (€1,325 Mil) to Dec. 2023 (€1,053 Mil) but then increased from Dec. 2023 (€1,053 Mil) to Mar. 2024 (€1,131 Mil).

Edwards Lifesciences's annual Ending Cash Position declined from Dec. 2021 (€768 Mil) to Dec. 2022 (€729 Mil) but then increased from Dec. 2022 (€729 Mil) to Dec. 2023 (€1,053 Mil).

Edwards Lifesciences Ending Cash Position Historical Data

The historical data trend for Edwards Lifesciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Ending Cash Position Chart

Edwards Lifesciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

1,065.96

986.56

767.65

729.33

1,052.72

Edwards Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															818.56	966.84	1,324.82	1,052.72	1,130.68

Edwards Lifesciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Edwards Lifesciences's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	708.473	+	344.243
	=	1,053

Edwards Lifesciences's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1056.16	+	74.52
	=	1,131

Edwards Lifesciences Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Edwards Lifesciences (WBO:EWLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (WBO:EWLS) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

EW:USA EW:Mexico 1EW:Italy EWL:Germany E1WL34:Brazil

Address

One Edwards Way, Irvine, CA, USA, 92614

Website

https://www.edwards.com

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Edwards Lifesciences (WBO:EWLS) Headlines

No Headlines